Excipients

Pharmaceutical excipients, which can be functional or inactive ingredients, work to enhance the medically relevant properties of the API. When used to promote ingredient qualities, excipients can be an asset for formulators to increase stability, bulk up the formulation, or enhance the therapeutic effects of the API. Below you can explore helpful resources including editorial coverage and webinars related to pharmaceutical excipients.

  • The Science Behind Hydrogen Peroxide Decontamination and Sterilization

    This publication was developed prior to the publication of technical details on low-pressure Hydrogen Peroxide sterilization. That process is significantly different from the near-ambient pressure vapor processes discussed herein and extending the concepts described to that process is not appropriate. Aerosol introduction of H2 O2 for ... read more

  • Beyond the Cleanroom: The Human and Technological Edge in Aseptic Manufacturing

    True expertise in aseptic manufacturing is more than knowledge - it is a commitment to adapting practices to keep pace with emerging technologies, diseases, and regulatory requirements. The pharmaceutical industry continuously evolves as it keeps pace with emerging threats to public health, burgeoning technologies, and new regulations, which at ... read more

  • The Future of Bispecific Antibodies

    After years of research and development, the field of bispecific antibodies (BsAbs) is gaining momentum. More than a dozen bispecific antibodies have secured FDA approval. These new therapies have added much-needed therapeutic value to challenging disease states such as relapsed/refractory multiple myeloma. In 12 months, three distinct CD3-engaging... read more

  • Shifting Sands: From Sensitivity to Accuracy in Bioanalysis

    In recent years, regulatory focus has notably shifted from sensitivity to accuracy, underscoring a pivotal change in how we approach toxicological assessments. While sensitivity remains a critical requirement, our advancing understanding of toxicology has highlighted the crucial need for precise target analysis. This shift in focus is particularly ... read more

  • Driving Innovation in Antibody Therapeutics, From Basic Research to the Clinic

    Nearly 25 years after the first FDA-approved antibody-drug conjugate (ADC), the field of antibody therapeutics continues to evolve. Advances in antibody development and engineering, as well as transformative progress in our understanding of biological processes and disease etiology, have unlocked new possibilities. This, in turn, has fueled an ... read more

  • As Prototypes Are Refined into Standardized Solutions, It Is Time to Consider Robotics and Automation in Microbial QC

    At a time when the pharmaceutical industry is entering a new transformational phase, the promise that automation, robotics, and concomitant digitalization hold is getting more and more recognition. The transition has long reached manufacturing, and now it seems to be the turn of microbiological quality control. In the interview also published in ... read more
Page
Page

Webinars

  • <<
  • >>